Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Tacrolimus is effective for various skin conditions with fewer side effects than cyclosporine.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

A new mutation in the TMEM173 gene and a risk allele in IFIH1 cause a unique set of immune-related symptoms.

Early diagnosis and aggressive treatment are crucial for better outcomes in lymphomatoid granulomatosis.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Zinc supplementation may help improve treatment outcomes for chronic hepatitis C.

The secretome from mesenchymal stem cells is a promising treatment that may repair tissue and avoid side effects of stem cell transplantation.

Fat cells help recruit healing cells and build skin structure during wound healing.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

TRP channels in the skin are important for sensation and health, and targeting them could help treat skin disorders.

Beta-sitosterol has potential health benefits but needs more research to fully understand its effects and improve its use in treatments.

Wnt signaling is important for development and cell regulation but can cause diseases like cancer when not working properly.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.